Severe labetalol overdose in an 8-month-old infant

Paediatric Anaesthesia

Volumn 18, Issue 5, 2008, Pages 435-438

  Thorsteinsson, Adalbjörn ^a   Johannesdottir, Astridur ^a   EirÍksson, Herbert ^a   Helgason, Hróemar ^a  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Coarctation; Intoxication; Labetalol; Pharmacokinetic

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ISOFLURANE; LABETALOL; NITROPRUSSIDE SODIUM;

AORTA COARCTATION; ARTICLE; CASE REPORT; DIAPHORESIS; DROWSINESS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE INCREASE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG OVERDOSE; DRUG WITHDRAWAL; FEMALE; HEART MUSCLE CONTRACTILITY; HEART VALVE REGURGITATION; HEART VENTRICLE SIZE; HUMAN; HYPERTENSION; HYPOTENSION; INFANT; MEDICATION ERROR; PHARMACODYNAMICS; POSTOPERATIVE CARE; PRIORITY JOURNAL;

ANTIHYPERTENSIVE AGENTS; AORTIC COARCTATION; FEMALE; HUMANS; HYPERTENSION; INFANT; LABETALOL; MEDICATION ERRORS; POSTOPERATIVE COMPLICATIONS;

EID: 41749095178     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2008.02501.x     Document Type: Article

References (13)

1. Benedict CR, Grahame-Smith DG, Fisher A. Changes in plasma catecholamines and dopamine beta-hydroxylase after corrective surgery for coarctation of the aorta. Circulation 1978 57 : 598 602.
2. Rocchini AP, Rosenthal A, Barger AC et al. Pathogenesis of paradoxical hypertension after coarctation resection. Circulation 1976 54 : 382 387.
3. Sealy WC. Paradoxical hypertension after repair of coarctation of the aorta: a review of its causes. Ann Thorac Surg 1990 50 : 323 329.
4. Bojar RM, Weiner B, Cleveland RJ. Intravenous labetalol for the control of hypertension following repair of coarctation of the aorta. Clin Cardiol 1988 11 : 639 641.
5. Suresh S, Mahajan P, Kamat D. Emergency management of pediatric hypertension. Clin Pediatr (Phila) 2005 44 : 739 745.
6. MacCarthy EP, Bloomfield SS. Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects. Pharmacotherapy 1983 3 : 193 219.
7. Love JN, Howell JM, Litovitz TL et al. Acute beta blocker overdose: factors associated with the development of cardiovascular morbidity. J Toxicol Clin Toxicol 2000 38 : 275 281.
8. Homeida M, Jackson L, Roberts CJ. Decreased first-pass metabolism of labetalol in chronic liver disease. Br Med J 1978 2 : 1048 1050.
9. Haraldsson A, Geven W. Half-life of maternal labetalol in a premature infant. Pharm Weekbl Sci 1989 11 : 229 231.
10. Woodman TF, Johnson B. High pressure liquid chromatography on labetalol in serum or plasma. Ther Drug Monit 1981 3 : 371 375.
11. Zimmerman JL. Poisonings and overdoses in the intensive care unit: general and specific management issues. Crit Care Med 2003 31 : 2794 2801.
12. Louis WJ, Drummer OH, Tung LH. Actions of dilevalol on adrenoceptors. J Cardiovasc Pharmacol 1988 11 (Suppl 2 S5 S11.
13. Love JN, Howell JM, Klein-Schwartz W et al. Lack of toxicity from pediatric beta-blocker exposures. Hum Exp Toxicol 2006 25 : 341 346.